English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Innovation is slowing greatly in the pharmaceutical sector. It is consideredhere how part of the problem is due to overly limiting intellectual propertyrelations in the sector. On the other hand, computing and software inparticular are characterized by great richness of intellectual propertyframeworks. Could the intellectual property ecosystem of computing come to theaid of the biosciences and life sciences? We look at how the answer might wellbe yes, by looking at (i) the extent to which a drug mirrors a softwareprogram, and (ii) what is to be gleaned from trends in research publishing inthe life and biosciences.

Open Access, Intellectual Property, and How Biotechnology Becomes a New Software Science